What should we recommend to our patients with NAFLD regarding alcohol use? (Q27011312)

Naga Chalasani

series ordinal

2

1 reference

language of work or name

1 reference

July 2012

1 reference

The American Journal of Gastroenterology

published in

1 reference

volume

107

1 reference

issue

7

1 reference

page(s)

976-8

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Resveratrol improves health and survival of mice on a high-calorie diet

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Alcohol consumption and mortality among middle-aged and elderly U.S. adults

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Nonalcoholic fatty liver disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Alcohol consumption and digestive cancer mortality in Koreans: the Kangwha Cohort Study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Advances in pediatric nonalcoholic fatty liver disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Mortality associated with moderate intakes of wine, beer, or spirits.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3766378

Epidemiology of non-alcoholic fatty liver disease.

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Alcohol consumption appears to protect against non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.20

Prevalence of and risk factors for hepatic steatosis in Northern Italy

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22764020